Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 1,020 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Laser therapy Clear all

Conditions: Primary Open Angle Glaucoma or Ocular Hypertension
Interventions: Netarsudil ophthalmic solution 0.02%, Artificial tears; Drug
Lead sponsor: East Coast Institute for Research; Network
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Cicatrix, Dermabrasion, Coagulation, Laser
Interventions: Fractionated laser, Dermabrasion; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Edina, Minnesota

Conditions: Epilepsy, Temporal Lobe
Interventions: monitoring by depth electrode; Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Scar, Surgical Scar, Cicatrix, Cicatrix, Hypertrophic, Keloid
Interventions: 532nm KTP, 595nm PDL; Device
Lead sponsor: Cutera Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Lung Neoplasms, Liver Neoplasms, Kidney Neoplasms, Cancer
Interventions: Needle angle measurement; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Burn Scar, Hypertrophic Scarring, Procedural Sedation
Interventions: Remimazolam besylate, Propofol; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Laryngeal Diseases
Interventions: CO2 laser; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 88 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Scars
Interventions: 755nm Alexandrite Laser with handpiece 2, 755nm Alexandrite Laser with handpiece 1, 755nm Alexandrite Laser with handpiece 3; Device
Lead sponsor: Cynosure, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
Interventions: gemcitabine hydrochloride, floxuridine, proteomic profiling, matrix-assisted laser desorption/ionization time of flight mass spectrometry, liquid chromatography, yttrium Y 90 anti-CEA monoclonal antibody cT84.66, laboratory biomarker analysis, mass spectrometry, pharmacological study; Drug · Genetic · Other + 1 more
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2018
U.S. locations: 1
States / cities: Duarte, California

Conditions: Kidney Stone, Benign Prostatic Hyperplasia
Interventions: WellPrept, Standard Care; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
Interventions: Light-activated AU-011, Laser Activation; Drug · Device
Lead sponsor: Aura Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 13
States / cities: Tucson, Arizona • Los Angeles, California • Palo Alto, California + 10 more

Conditions: Female Pattern Baldness
Interventions: 1550nm non-ablative fractional laser, 1927 thulium fractional laser; Device
Lead sponsor: Goldman, Butterwick, Fitzpatrick and Groff; Other
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Vulvovaginal Atrophy
Interventions: Laser treatment; Device
Lead sponsor: El. En. SpA; Industry
Eligibility: 45 Years to 60 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Palo Alto, California • West Chester, Ohio

Conditions: Photobiomodulation Therapy, Photomedicine, Low-Level Laser Therapy, Performance Enhancement, Quadriceps, Special Operations Readiness
Interventions: THOR3 training + Photobiomodulation Therapy (PBMT), THOR3 training + sham PBMT; Device
Lead sponsor: Musculoskeletal Injury Rehabilitation Research for Operational Readiness; Federal
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Joint Base Lewis McChord, Washington

Conditions: Abscess
Interventions: Methylene Blue, Lipid Emulsion, Insertion of optical fiber, Laser Illumination (pre-defined dose), Optical Spectroscopy Measurement, Laser Illumination (patient-specific dose), Standard of care abscess drainage; Drug · Device · Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 2
States / cities: Rochester, New York

Conditions: Myopia
Interventions: LASIK; Procedure
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Stanford, California

Conditions: Symptoms of Anxiety
Interventions: Attention bias assessment and modification, Transcranial photobiomodulation; Behavioral · Device
Lead sponsor: Francisco Gonzalez-Lima, PhD; Other
Eligibility: 18 Years to 100 Years
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Vulvodynia
Interventions: CO2 laser, Lidocaine patch 5%; Device · Drug
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Denville, New Jersey

Conditions: Neoplasms Prostate, Cancer of the Prostate
Interventions: Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer; Device
Lead sponsor: Urological Research Network, LLC; Other
Eligibility: 50 Years and older · Male only
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2038
U.S. locations: 1
States / cities: Miami Lakes, Florida

Conditions: Hypersomnolence
Interventions: NextSense EEG-enabled earbuds, Ellcie Healthy eyeglasses, Drug Holiday; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Age Related Macular Degeneration
Interventions: Photobiomodulation; Device
Lead sponsor: LumiThera, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Port Richey, Florida

Conditions: Leukoplakia, Erythroplakia
Interventions: PDL-585, ScleroPLUS laser, 5-Aminolevulinic Acid (Levulan KerastickTM), Fluorescence Diagnosis Imaging; Device · Drug · Procedure
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Burn Scars
Interventions: Pulse-Dye Laser, Sham; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 9 Years to 21 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Acne Scarring
Interventions: Fractionated Laser Resurfacing; Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 59 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Detroit, Michigan

Search by objective public record fields.

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

Laser Resurfacing Versus Dermabrasion for Scar Revision

The Utility of NIOM During LITT for Refractory MTLE

Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars

A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy

Remimazolam vs Propofol in Laser Burn Cases

Comparison of Office-based KTP and CO2 Laser Outcomes in Patients With Vocal Cord Lesions.

Clinical and Histological Evaluation of the 755nm Alexandrite Laser With Handpiece for the Treatment of Scars

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Utilization of a Web-Based Application to Improve Patient Health Literacy and Reduce Clinic Visit Times in Holmium Laser Enucleation of the Prostate (HoLEP) Procedures and Kidney Stone Surgery

Study in Subjects With Small Primary Choroidal Melanoma

1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss

Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy

Photomedicine Project 14: PBMT for Performance Enhancement in SOF

Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses

Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK

Transcranial Photobiomodulation in Anxiety Disorders

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

Sleep/Wake State Assessment with Non-invasive Earbuds

Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration

Treatment of Oral Premalignant Lesions With 5-ALA PDT

Laser Therapy for Treating Hypertrophic Burn Scars in Children

Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin